MEDITE® Group is a medical technology company specializing in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. MEDITE is poised to become a disruptive force from rapid revenue and market share growth resulting from the introduction of major innovative products in the multibillion dollar global histology and cytology cancer detection marketplace. 

After 40 years in business, MEDITE is a company with a well-established international brand name, 80 employees in four countries, a distribution network to about 70 countries worldwide and a wide range of products for anatomic pathology, histology and cytology laboratories.